Syros Reports Second Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. DAL
5. AWK
6. SPCX
7. III
8. TTEC
9. SNY

Go back to Syros Reports Second Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Tops Q2 EPS by 7c

August 7, 2018 7:34 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q2 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).

The second half of 2018 promises to be an important time for Syros, said Nancy Simonian, M.D., Chief Executive Officer of Syros. Over the next several months, we plan... More